We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
Suppression of myoclonus in SCA2 by piracetam / A. D., Rosa; P., Striano; F., Barbieri; A. d., Falco; C., Rinaldi; T., Tucci; Striano, Salvatore; Filla, Alessandro; Michele, G. D.. - In: MOVEMENT DISORDERS. - ISSN 0885-3185. - ELETTRONICO. - 21:(2006), pp. 116-118. [10.1002/mds.20683]
Suppression of myoclonus in SCA2 by piracetam.
STRIANO, SALVATORE;FILLA, ALESSANDRO;G. D. Michele
2006
Abstract
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
